Blog
RSS FeedPosted by Michael Wonder on 14 Oct 2020
Scotland backs two myeloma drugs turned down by NICE in England
14 October 2020 - A north-south divide threatens to emerge in multiple myeloma in the UK, after the Scottish Medicines ...
Posted by Michael Wonder on 12 Oct 2020
SMC accepts Bavencio (avelumab) in combination with axitinib for the first-line treatment of adult patients with advanced or metastatic renal cell carcinoma
12 October 2020 - Merck and Pfizer announced today that the Scottish Medicines Consortium has accepted the immunotherapy Bavencio (avelumab) for ...
Posted by Michael Wonder on 12 Oct 2020
SMC - October 2020 decisions
12 October 2020 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today ...
Posted by Michael Wonder on 06 Oct 2020
Update on SMC remobilisation
2 October 2020 - SMC business recovery following the early stages of the COVID-19 pandemic continues to progress well. ...
Posted by Michael Wonder on 23 Sep 2020
SMC plays key role in helping to secure access to COVID-19 treatments
15 September 2020 - The Scottish Medicines Consortium is part of a UK-wide multi-agency initiative to secure access to potential ...
Posted by Michael Wonder on 09 Sep 2020
Scottish Medicines Consortium accepts nasal spray for depression previously rejected by NICE
8 September 2020 - Esketamine nasal spray can now be provided on the NHS in Scotland for adults with major depressive ...
Posted by Michael Wonder on 09 Sep 2020
Alimera Sciences obtains reimbursement approval for Iluvien use in non-infectious posterior uveitis in Scotland
8 September 2020 - Alimera Sciences announces that the Scottish Medicines Consortium, after completing its assessment and review, has accepted (per ...
Posted by Michael Wonder on 08 Sep 2020
SMC accepts three new health technologies for interim use
7 September 2020 - In what appears to be a new process, the SMC has accepted three new technologies for ...
Posted by Michael Wonder on 08 Sep 2020
ICR welcomes approval of immunotherapy for head and neck cancer in Scotland but warns of ‘home nations lottery’
7 September 2020 - The Institute of Cancer Research, London, has welcomed the approval by the Scottish Medicines Consortium of ...
Posted by Michael Wonder on 07 Sep 2020
Four new medicines accepted by SMC through an expedited approach
7 September 2020 - Medicines accepted to minimise delay in patient access following the early phase of the COVID-19 pandemic. ...
Posted by Michael Wonder on 07 Sep 2020
SMC recommends Merck's Keytruda for another two indications
7 September 2020 - Pembrolizumab (Keytruda) has been accepted for the treatment of patients with head and neck squamous cell carcinoma ...
Posted by Michael Wonder on 07 Sep 2020
SMC accepts Spravato (esketamine) nasal spray for use in adults with treatment-resistant major depressive disorder in Scotland
7 September 2020 - SMC acceptance comes less than a week after second rejection by NICE. ...
Posted by Michael Wonder on 07 Sep 2020
SMC - September 2020 decisions
7 September 2020 - The SMC has today published advice accepting fourteen new medicines. ...
Posted by Michael Wonder on 10 Aug 2020
SMC - August 2020 decisions
10 August 2020 - The Scottish Medicines Consortium has today published advice accepting neratinib (Nerlynx) for the treatment of breast ...
Posted by Michael Wonder on 09 Aug 2020
'Tears of joy' as new drug ready for cystic fibrosis patient
8 August 2020 - A woman waiting for the approval of a delayed drug that could save her life says ...